Catherine Martineau-Huynh, Co-founder of TheraPanacea, talks about a new era for radiotherapy. With Nikos Paragios, the start-up was created to apply artificial intelligence to medicine. The company’s software uses AI to identify the organs that should be protected and determines the optimum beam to target harmful cells and leave healthy organs unscathed. A revolutionary idea for the medical sector, improving the technical and human aspects of care to benefit patients and cutting doctors' workload by around 95%! TheraPanacea won an EDF Pulse start-up award in 2019.